Oncology Central

First-time evidence that individuals at risk of developing AML can be identified, years before diagnosis

An international group of researchers have discovered that analyzing blood tests for changes in the DNA code can identify individuals at high risk of developing acute myeloid leukaemia (AML) years before diagnosis. The findings were recently published in Nature.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.